CRNDE drives HCC progression by enhancing tumor growth, recruiting G-MDSCs, and inhibiting T cell invasion via TLR3 binding, NF-κB activation, and CXCL3 upregulation. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.